25.60PLN-4.83%Mkt Cap: 36.99M $P/E: —1d ago
Poltreg S.A., a biotechnology company, researches and develops therapies for autoimmune diseases in Poland. Its product pipeline includes PTG-OO7 + Rituximab which is in phase II clinical trial to treat presymptomatic T1…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap36.99M $
Enterprise Value38.43M $
Revenue (TTM)—
Gross Profit-1.36M $
Net Income (TTM)-6.58M $
Revenue/Share—
Last Price25.60 PLN
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees37
CountryPL
SectorHealthcare
IndustryBiotechnology
ISINPLPLTRG00038
Valuation
P/E (Trailing)—
P/E (Forward)6.63
PEG—
EV/EBITDA-6.87
EV/Revenue—
P/S—
P/B3.23
EPS (TTM)-5.86
EPS (Forward)—
52W Range
16.0048% of range36.00
52W High36.00 PLN
52W Low16.00 PLN
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-60.00%
ROA-35.64%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.06M $
CapEx (TTM)137.52K $
FCF Margin—
FCF Yield-13.39%
Net Debt-382.68K $
Net Debt/EBITDA0.07
Balance Sheet
Debt/Equity0.18
Current Ratio1.82
Quick Ratio1.68
Book Value/Sh7.852 PLN
Cash/Share1.541 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.5.43M
Float3.82M
Insiders27.85%
Institutions27.14%
Technical
SMA 5021.29 (+20.2%)
SMA 20022.61 (+13.2%)
Beta0.82
S&P 52W Chg19.97%
Avg Vol (30d)9.55K
Avg Vol (10d)5.76K
Technical Indicators
RSI (14)76.4
MACD1.4811
MACD Signal0.6146
MACD Hist.+0.8665
BB Upper25.33 PLN
BB Middle19.98 PLN
BB Lower14.63 PLN
BB Width53.53%
ATR (14)1.478 PLN
Vol Ratio (20d)0.91x